Aug 10
|
Joint Second Quarter 2025 Earnings: EPS Beats Expectations
|
Aug 9
|
A Look At The Intrinsic Value Of The Joint Corp. (NASDAQ:JYNT)
|
Aug 8
|
The Joint Corp (JYNT) Q2 2025 Earnings Call Highlights: Navigating Growth and Challenges
|
Aug 7
|
The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates
|
Aug 7
|
The Joint Corp. Reports Second Quarter 2025 Financial Results
|
Jul 30
|
The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges
|
Jul 24
|
The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results
|
Jun 25
|
The Joint Corp. Signs Binding Agreement to Sell 31 Corporate Clinics in Arizona and New Mexico and to Acquire Regional Developer Rights in the Northwest Region and Refranchises Five Corporate Clinics in the Kansas City Region, Tracking to Become Larges...
|
Jun 20
|
With 47% ownership, The Joint Corp. (NASDAQ:JYNT) has piqued the interest of institutional investors
|
Jun 4
|
The Joint Corp. Appoints Sandi Karrmann as Director
|
May 22
|
The Joint Corp. Announces Christopher M. Grandpre Elected as Director
|
May 2
|
The Joint Chiropractic Observes National Arthritis Awareness Month in May
|
May 1
|
The Joint Chiropractic Ranks 37 on Entrepreneur's Fastest-Growing Franchises List, Joins the 10+ Club
|
Mar 15
|
Joint Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
Mar 14
|
The Joint Corp (JYNT) Q4 2024 Earnings Call Highlights: Strong Sales Growth Amidst Economic ...
|
Mar 13
|
The Joint Corp. (JYNT) Matches Q4 Earnings Estimates
|
Mar 13
|
The Joint Corp. Reports Fourth Quarter and Year-end 2024 Financial Results
|
Mar 11
|
The Joint Corp. Names SVP Development
|
Feb 20
|
The Joint Corp. to Host Conference Call on Thursday, March 13th to Discuss Fourth Quarter and Year-end 2024 Results
|
Jan 17
|
When Should You Buy The Joint Corp. (NASDAQ:JYNT)?
|